IgG monitoring to identify the risk for development of infection in heart transplant recipients.
about
The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMVClinical immune-monitoring strategies for predicting infection risk in solid organ transplantationImmunological risk factors for infection after immunosuppressive and biologic therapies.Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial.Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?Intravenous immunoglobulin as an intervention strategy of risk factor modification for prevention of severe infection in heart transplantation.Does increasing immunoglobulin levels impact survival in solid organ transplant recipients with hypogammaglobulinemia?Evaluation of an immunological score to assess the risk of severe infection in heart recipients.What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A meta-analysis.Humoral and cellular monitoring to predict the development of infection in Crohn's disease patients beginning treatment with infliximab.Micro-bead injection spectroscopy for label-free automated determination of immunoglobulin G in human serum.Alterations of naïve and memory B-cell subsets are associated with risk of rejection and infection in heart recipients.Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipientsSimultaneous Monitoring of Cytomegalovirus-Specific Antibody and T-cell levels in Seropositive Heart Transplant RecipientsRestoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections
P2860
Q26768481-535CB50B-1BFB-425C-B705-850A8D56A010Q26998832-366B87B5-E4AC-4044-B5F9-8C1727302C58Q37866813-FDAC72E8-10D9-4D34-B2A1-1C3F5BE59C22Q39379187-E7EB89F7-1654-43A2-B3AE-3D776A8C35FEQ41537054-BF3A8A50-8A2E-46C1-87F9-140B3C5BDAF3Q41577767-FB7D265A-B62B-40E4-9A96-3E38DBBB212AQ41746594-395DE002-E261-435B-BD27-CBDBFEC048BAQ41758384-B23AADC6-DC87-4D73-B6CC-CB27032C1F42Q42252234-3323FCC5-A33A-45DB-9A3A-B08E4089F11DQ43450427-516D24B5-9A4C-4E4B-815B-8BCC0B606A3DQ47827475-CCEAEF79-6C70-41A8-9C8F-57F0131F70B3Q50897404-5D6A42E2-BF35-4C2A-964C-25243FF11B22Q57568967-0D844E1B-EF2B-4F23-8BED-BACA2CCE7885Q57568998-4F892106-E702-4ACC-A05B-C523963A2F17Q57569065-BD9B7255-D905-4F1D-849F-9C9579588177
P2860
IgG monitoring to identify the risk for development of infection in heart transplant recipients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
IgG monitoring to identify the ...... n heart transplant recipients.
@en
IgG monitoring to identify the ...... n heart transplant recipients.
@nl
type
label
IgG monitoring to identify the ...... n heart transplant recipients.
@en
IgG monitoring to identify the ...... n heart transplant recipients.
@nl
prefLabel
IgG monitoring to identify the ...... n heart transplant recipients.
@en
IgG monitoring to identify the ...... n heart transplant recipients.
@nl
P2093
P2860
P50
P1476
IgG monitoring to identify the ...... in heart transplant recipients
@en
P2093
Fernandez-Cruz E
Fernandez-Yañez J
Rodriguez-Molina JJ
P2860
P356
10.1111/J.1399-3062.2006.00136.X
P577
2006-03-01T00:00:00Z